As of December 2025, GLP-1 RA prescriptions account for more than 7% of all prescriptions. Tirzepatide continues to be the most prescribed anti-diabetic (ADM) and anti-obesity (AOM) medication (sold as Mounjaro and Zepbound, respectively) and showed the largest...
Among women prescribed a semaglutide or tirzepatide medication, the percentage with a PCOS diagnosis increased from 4.6% in 2021 to 5.7% in 2025, a 23.9% relative increase. Nearly all PCOS patients prescribed semaglutide or tirzepatide also had obesity or type 2...
In patients with CKD and diabetes, anemia prevalence and severity increased from stage 1 to stage 5, with overall anemia rising from 46.4% to 85.0% and severe anemia from 2.5% to 11.8% Erythropoiesis-stimulating agents (ESAs) and IV iron use rose as hemoglobin levels...
Overall GLP-1 prescribing rates (GLP-1 RA prescriptions per total prescriptions) in September 2025 remained stable relative to June 2025 (+4.6%). As of September 2025, GLP-1 prescriptions account for 6.5 out of every 100 prescriptions in the US. Tirzepatide continues...
Infections remain one of the most concerning complications following ureteroscopy (URS), a common procedure to examine or treat kidney stones. Even though URS is considered a safe and routine procedure, postoperative infections can lead to serious outcomes, including...
